GUTK treatment in HCC cells led to a decrease in F-actin expression levels, which was accompanied by the inactivation of Rho family GTPases, as evidenced by the reduction in the phosphorylation of Rac1/Cdc42, as well as the reduction of their target proteins WAVE-2 and N-WASP. This evidence concerns the gene CDC42 and hepatocellular carcinoma.